Eriomin is a branded, standardized extract of eriocitrin—a bioflavonoid found naturally in lemon peel and other citrus fruits. It is being studied as a dietary supplement for blood sugar management and metabolic health, with early research suggesting it may help improve insulin sensitivity and reduce oxidative stress. While evidence is still preliminary and mostly derived from animal and small human trials, eriomin fits into a growing category of natural compounds investigated for cardiometabolic support alongside ingredients like berberine and chromium.
What Eriocitrin Is and How It Works
Eriocitrin is a flavonoid compound—a type of plant polyphenol known for antioxidant and anti-inflammatory activity. It is one of the major bioactive compounds in lemon peel, where it comprises about 0.3–0.5% of the dry weight. Traditional citrus-based remedies have long been used in folk medicine, but modern supplement formulations now isolate and standardize eriocitrin to provide consistent, measurable doses.
The proposed mechanism involves several pathways. Eriocitrin is thought to act as an antioxidant, neutralizing free radicals that can impair insulin secretion and glucose metabolism. It may also modulate inflammatory signaling pathways implicated in metabolic dysfunction, and some research suggests it could enhance glucose uptake in cells and improve mitochondrial function. Additionally, eriocitrin may inhibit enzymes involved in carbohydrate digestion, potentially slowing glucose absorption after meals.
Current Evidence on Blood Sugar and Metabolic Effects
Laboratory and animal studies have shown promise. In rodent models of metabolic dysfunction, eriocitrin supplementation was associated with improved fasting glucose levels, better glucose tolerance, and enhanced insulin sensitivity. Several cell-culture experiments demonstrated that eriocitrin can stimulate glucose uptake and improve insulin receptor signaling.
Human evidence is more limited. A small randomized controlled trial published in a peer-reviewed journal found that participants taking eriocitrin showed modest improvements in fasting blood glucose and hemoglobin A1c (a marker of long-term glucose control) compared to placebo over 12 weeks. Another small study suggested that eriocitrin may help reduce postprandial (after-meal) blood sugar spikes in people with prediabetes. However, these trials involved fewer than 100 participants each, and results were modest. Larger, longer-term studies in diverse populations are needed to confirm efficacy and identify which individuals may benefit most.
Regarding body composition and weight, preliminary data suggest eriocitrin may support healthy weight management through improved metabolic rate and reduced fat accumulation in animal models, but human evidence is absent. For lipid profiles, one small trial noted modest improvements in triglycerides, though LDL and HDL changes were not significant.
Bioavailability and Dose Form
Eriocitrin is a polar molecule with moderate bioavailability. When ingested, a portion is absorbed in the small intestine, while some passes to the colon where it undergoes metabolism by the microbiota, generating potentially bioactive metabolites. Peak plasma concentrations typically occur 1–2 hours after oral intake. The eriomin extract is usually standardized to 30–50% eriocitrin by weight, and is supplied in capsule, tablet, or powder form.
Absorption can be influenced by food intake and individual gut flora composition. Taking eriocitrin with a meal containing fat may enhance absorption slightly. Some formulations combine eriocitrin with other bioavailability enhancers, such as black pepper extract (piperine), though evidence for this synergy with eriocitrin specifically is limited.
Typical Dosing and Usage
Most research studies have employed doses ranging from 100 to 500 mg of eriocitrin daily, typically given in one or two divided doses. A common supplement dose is 250–500 mg once or twice daily, often standardized to deliver 100–250 mg of elemental eriocitrin per serving. Some formulations also combine eriocitrin with complementary ingredients—alpha-lipoic acid is one such pairing, as both compounds are studied for metabolic and antioxidant support.
Onset of effects is gradual. Most trial participants did not see meaningful changes until after 4–8 weeks of consistent use. For best results, consistency is key: daily supplementation is recommended over sporadic use.
Safety, Tolerability, and Interactions
Eriocitrin is generally regarded as safe and well-tolerated. No serious adverse events were reported in the small human trials conducted to date. Mild side effects are uncommon but may include mild gastrointestinal upset (nausea, mild diarrhea) in sensitive individuals, particularly at higher doses or on an empty stomach.
Potential interactions warrant attention: eriocitrin may have mild anticoagulant properties and could theoretically potentiate blood-thinning medications such as warfarin or antiplatelet agents. While clinical significance remains unclear, individuals on these medications should discuss eriocitrin use with their healthcare provider beforehand. Eriocitrin may also interact with certain antidiabetic medications by enhancing glucose-lowering effects; those on insulin or glucose-lowering drugs should monitor blood sugar closely if adding eriocitrin and adjust dosing under medical supervision if needed.
Pregnancy and lactation: safety data is insufficient. Pregnant and breastfeeding women should avoid eriomin supplements unless directed otherwise by their healthcare provider. Individuals with citrus allergies should avoid eriocitrin products.
Who May Benefit Most
Eriocitrin may be most appropriate for adults seeking natural support for blood sugar stability, particularly those with prediabetes or metabolic syndrome who are making lifestyle changes (diet and exercise). It may also appeal to individuals interested in antioxidant and anti-inflammatory support for general metabolic wellness.
Eriocitrin is not a substitute for medical treatment of diabetes. Those with diagnosed diabetes, taking glucose-lowering medications, or with significant metabolic complications should work with their healthcare team before beginning any new supplement regimen.
People with severe liver or kidney disease, those taking numerous medications, and pregnant or nursing individuals should consult a clinician before use. Athletes and those subject to supplement screening should verify that their specific product is free of banned substances, although eriocitrin itself is not banned by major sports organizations.
Practical Buying and Quality Considerations
Quality and consistency vary significantly among commercial eriocitrin products. Look for supplements that are standardized to a declared percentage of eriocitrin (typically 30–50%), as this ensures you receive a consistent, research-relevant dose. Third-party testing by accredited labs (such as NSF, USP, or ConsumerLab) is highly recommended to verify label claims and screen for contaminants.
Check the ingredient label for added fillers, binders, or artificial additives. Some brands combine eriomin with other metabolism-supporting compounds; while such formulations may offer convenience, they can also complicate dose titration and interpretation of effects. If you are trialing eriocitrin, a single-ingredient product is clearer for assessing your individual response.
Price varies widely. Expect to pay $15–40 per month for a quality, standardized eriocitrin supplement. Extremely cheap products may contain minimal eriocitrin despite label claims; conversely, premium pricing does not always correlate with superior efficacy.
When to Talk to Your Healthcare Provider
Consult your doctor or registered dietitian before starting eriomin if you have diabetes or prediabetes (especially if on medication), take blood-thinning drugs, have liver or kidney disease, are pregnant or nursing, have a citrus allergy, or take multiple supplements or medications. If you experience unusual symptoms—such as dizziness, persistent gastrointestinal upset, unusual bleeding or bruising, or hypoglycemic episodes—stop use and seek medical advice. After 8–12 weeks of consistent use, reassess with your healthcare provider to determine whether eriocitrin is contributing to your health goals and whether to continue.